Taiho Pharmaceutical Selects Medidata Solutions, Inc. Rave for Global Trials
7/28/2008 9:04:18 AM
NEW YORK & TOKYO--(BUSINESS WIRE)--Medidata Solutions, a leading provider of clinical trial solutions, today announced that Taiho Pharmaceutical Co., Ltd. will implement Medidata Rave® as its electronic data capture (EDC), management and reporting solution of choice. Taiho Pharmaceutical, a specialty pharmaceutical company headquartered in Tokyo, plans to use Medidata Rave to conduct a Phase III trial for cervical cancer therapy in Japan, Taiwan and South Korea.